UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 6,664	$ 8,400
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation	355	395
Amortization	2,902	1,128
Gain on Investments	0	(32)
Provision for (recovery of) losses on accounts receivable	(2)	1
Amortization of Right of Use Assets	19	0
(Gain) loss on disposal of assets	0	(418)
Deferred income taxes	(278)	(225)
Stock-based compensation expense	56	42
Tax benefit attributable to exercise of stock options	15	39
Changes in operating assets and liabilities:
Accounts receivable and other receivables	(1,256)	(992)
Inventories	(2,322)	(45)
Prepaid expenses and other current assets	24	(3)
Accounts payable	(123)	51
Accrued expenses	(1,011)	(594)
Total adjustments	(1,621)	(653)
Net cash provided by operating activities	5,043	7,747
CASH FLOWS FROM INVESTING ACTIVITIES:
Property and equipment	(130)	(201)
Intangible assets	(21,000)	0
Proceeds from sale of investments	0	74
Proceeds from sale of property and equipment	0	862
Net cash provided by (used in) investing activities	(21,130)	735
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	171	347
Common stock purchased and retired	(398)	0
Payment of dividends	(2,055)	(2,011)
Net cash provided by (used in) financing activities	(2,282)	(1,664)
Effect of exchange rate changes on cash	137	(820)
Net increase (decrease) in cash and cash equivalents	(18,232)	5,998
Cash at beginning of period	51,112	39,875
Cash at end of period	32,880	45,873
Cash paid during the period for income taxes	2,937	3,016
Cash paid during the period for interest	$ 0	$ 0